Appropriate supplementation, when indicated based on individual assessment rather than routine use, can help address nutritional gaps during tirzepatide therapy
Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial
In value terms, tirzepatide could command 30% of the drug class by 2031 if HTA bottlenecks clear and price parity tightens
If you're meeting your protein and fiber targets across two or three small meals, snacks are optional
Experience Renewed Vitality with Longevity Medical Spa Discover a new chapter in wellness with Longevity Medical Spa in OKC
Long-term safety data are lacking, and as with other peptides affecting tissue remodeling, theoretical concerns about promoting abnormal cell growth exist